+データを開く
-基本情報
登録情報 | データベース: PDB / ID: 2x1v | ||||||
---|---|---|---|---|---|---|---|
タイトル | Crystal Structure of the activating H-Ras I163F mutant in Costello Syndrome, bound to MG-GDP | ||||||
要素 | GTPASE HRASHRAS | ||||||
キーワード | HYDROLASE (加水分解酵素) / S-NITROSYLATION / DISEASE MUTATION / PALMITATE (パルミチン酸) / METHYLATION (メチル化) / PRENYLATION (プレニル化) / CELL MEMBRANE (細胞膜) / PROTO-ONCOGENE (がん遺伝子) / GTPASE PROTEIN (GTPアーゼ) / GOLGI APPARATUS (ゴルジ体) | ||||||
機能・相同性 | 機能・相同性情報 GTPase complex / oncogene-induced cell senescence / positive regulation of ruffle assembly / negative regulation of GTPase activity / regulation of neurotransmitter receptor localization to postsynaptic specialization membrane / T-helper 1 type immune response / positive regulation of wound healing / positive regulation of miRNA metabolic process / defense response to protozoan / Signaling by RAS GAP mutants ...GTPase complex / oncogene-induced cell senescence / positive regulation of ruffle assembly / negative regulation of GTPase activity / regulation of neurotransmitter receptor localization to postsynaptic specialization membrane / T-helper 1 type immune response / positive regulation of wound healing / positive regulation of miRNA metabolic process / defense response to protozoan / Signaling by RAS GAP mutants / Signaling by RAS GTPase mutants / Activation of RAS in B cells / RAS signaling downstream of NF1 loss-of-function variants / SOS-mediated signalling / Activated NTRK3 signals through RAS / Activated NTRK2 signals through RAS / SHC1 events in ERBB4 signaling / Signalling to RAS / positive regulation of protein targeting to membrane / SHC-related events triggered by IGF1R / Activated NTRK2 signals through FRS2 and FRS3 / Estrogen-stimulated signaling through PRKCZ / adipose tissue development / SHC-mediated cascade:FGFR3 / MET activates RAS signaling / : / Schwann cell development / PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases / Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants / Signaling by PDGFRA extracellular domain mutants / SHC-mediated cascade:FGFR2 / SHC-mediated cascade:FGFR4 / Signaling by FGFR4 in disease / SHC-mediated cascade:FGFR1 / Erythropoietin activates RAS / protein-membrane adaptor activity / FRS-mediated FGFR3 signaling / Signaling by FLT3 ITD and TKD mutants / FRS-mediated FGFR2 signaling / FRS-mediated FGFR4 signaling / Signaling by FGFR3 in disease / FRS-mediated FGFR1 signaling / p38MAPK events / Tie2 Signaling / Signaling by FGFR2 in disease / GRB2 events in EGFR signaling / EPHB-mediated forward signaling / SHC1 events in EGFR signaling / EGFR Transactivation by Gastrin / Signaling by FLT3 fusion proteins / FLT3 Signaling / 髄鞘 / Signaling by FGFR1 in disease / Ras activation upon Ca2+ influx through NMDA receptor / GRB2 events in ERBB2 signaling / NCAM signaling for neurite out-growth / CD209 (DC-SIGN) signaling / SHC1 events in ERBB2 signaling / Downstream signal transduction / Constitutive Signaling by Overexpressed ERBB2 / Insulin receptor signalling cascade / intrinsic apoptotic signaling pathway / 低分子量GTPアーゼ / G protein activity / Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants / VEGFR2 mediated cell proliferation / positive regulation of epithelial cell proliferation / regulation of actin cytoskeleton organization / FCERI mediated MAPK activation / animal organ morphogenesis / positive regulation of JNK cascade / Signaling by ERBB2 TMD/JMD mutants / regulation of long-term neuronal synaptic plasticity / RAF activation / positive regulation of MAP kinase activity / Signaling by high-kinase activity BRAF mutants / Constitutive Signaling by EGFRvIII / MAP2K and MAPK activation / Signaling by ERBB2 ECD mutants / Signaling by ERBB2 KD Mutants / Signaling by SCF-KIT / cellular response to gamma radiation / positive regulation of GTPase activity / エンドサイトーシス / Regulation of RAS by GAPs / Negative regulation of MAPK pathway / RAS processing / Signaling by RAF1 mutants / GDP binding / Signaling by moderate kinase activity BRAF mutants / Paradoxical activation of RAF signaling by kinase inactive BRAF / Signaling downstream of RAS mutants / 走化性 / 分裂促進因子活性化タンパク質キナーゼ / positive regulation of type II interferon production / 細胞老化 / positive regulation of fibroblast proliferation / Signaling by BRAF and RAF1 fusions / DAP12 signaling / Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants 類似検索 - 分子機能 | ||||||
生物種 | HOMO SAPIENS (ヒト) | ||||||
手法 | X線回折 / 分子置換 / 解像度: 1.7 Å | ||||||
データ登録者 | Anand, K. | ||||||
引用 | ジャーナル: To be Published タイトル: Crystal Structure of the Activating H-Ras I163F Mutant in Costello Syndrome, Bound to Mg-Gdp 著者: Anand, K. / Parret, A. / Denayer, E. / Petrova, B. / Legius, E. / Scheffzek, K. | ||||||
履歴 |
|
-構造の表示
構造ビューア | 分子: MolmilJmol/JSmol |
---|
-ダウンロードとリンク
-ダウンロード
PDBx/mmCIF形式 | 2x1v.cif.gz | 72.8 KB | 表示 | PDBx/mmCIF形式 |
---|---|---|---|---|
PDB形式 | pdb2x1v.ent.gz | 53.8 KB | 表示 | PDB形式 |
PDBx/mmJSON形式 | 2x1v.json.gz | ツリー表示 | PDBx/mmJSON形式 | |
その他 | その他のダウンロード |
-検証レポート
アーカイブディレクトリ | https://data.pdbj.org/pub/pdb/validation_reports/x1/2x1v ftp://data.pdbj.org/pub/pdb/validation_reports/x1/2x1v | HTTPS FTP |
---|
-関連構造データ
関連構造データ | 4q21S S: 精密化の開始モデル |
---|---|
類似構造データ |
-リンク
-集合体
登録構造単位 |
| ||||||||
---|---|---|---|---|---|---|---|---|---|
1 |
| ||||||||
単位格子 |
|
-要素
#1: タンパク質 | 分子量: 18909.207 Da / 分子数: 1 / 断片: G-DOMAIN, RESIDUES 1-166 / 変異: YES / 由来タイプ: 組換発現 / 由来: (組換発現) HOMO SAPIENS (ヒト) / 発現宿主: ESCHERICHIA COLI (大腸菌) / 参照: UniProt: P01112, 低分子量GTPアーゼ |
---|---|
#2: 化合物 | ChemComp-GDP / |
#3: 水 | ChemComp-HOH / |
構成要素の詳細 | ENGINEERED |
-実験情報
-実験
実験 | 手法: X線回折 / 使用した結晶の数: 1 |
---|
-試料調製
結晶 | マシュー密度: 2.82 Å3/Da / 溶媒含有率: 56.07 % / 解説: DATA WERE TWINNED AND REFINED USING PHENIX.XTRIAGE |
---|---|
結晶化 | pH: 7.6 詳細: 18% POLYETHYLENE GLYCOL (PEG) 6000, 100 MM HEPES PH 7.4, 150 MM MGCL2. |
-データ収集
回折 | 平均測定温度: 100 K |
---|---|
放射光源 | 由来: 回転陽極 / タイプ: RIGAKU / 波長: 1.5418 |
検出器 | タイプ: MAR scanner 345 mm plate / 検出器: IMAGE PLATE / 日付: 2008年5月15日 |
放射 | プロトコル: SINGLE WAVELENGTH / 単色(M)・ラウエ(L): M / 散乱光タイプ: x-ray |
放射波長 | 波長: 1.5418 Å / 相対比: 1 |
Reflection twin | Operator: h,-h-k,-l / Fraction: 0.482 |
反射 | 解像度: 1.7→20 Å / Num. obs: 1054 / % possible obs: 100 % / Observed criterion σ(I): 2 / 冗長度: 15 % / Rmerge(I) obs: 0.03 / Net I/σ(I): 46.14 |
反射 シェル | 解像度: 1.7→1.8 Å / 冗長度: 6.85 % / Rmerge(I) obs: 0.09 / Mean I/σ(I) obs: 5.73 / % possible all: 100 |
-解析
ソフトウェア |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
精密化 | 構造決定の手法: 分子置換 開始モデル: PDB ENTRY 4Q21 解像度: 1.7→28.285 Å / SU ML: 0.05 / σ(F): 1.99 / 位相誤差: 29.13 / 立体化学のターゲット値: TWIN_LSQ_F 詳細: HRAS ILE163PHE PATIENT MUTANT LACK BOTH LOOPS THAT ARE INVOLVED IN THE (DISORDERED RESIDUE 30-38 AND 58-69) SWITCH I AND II.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
溶媒の処理 | 減衰半径: 0.9 Å / VDWプローブ半径: 1.55 Å / 溶媒モデル: FLAT BULK SOLVENT MODEL / Bsol: 96.88 Å2 / ksol: 0.413 e/Å3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
原子変位パラメータ |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
精密化ステップ | サイクル: LAST / 解像度: 1.7→28.285 Å
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
拘束条件 |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
LS精密化 シェル |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
精密化 TLS | 手法: refined / Origin x: 16.9216 Å / Origin y: -28.123 Å / Origin z: -0.8268 Å
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
精密化 TLSグループ | Selection details: CHAIN A |